Navigation Links
NCCN Holds Oncology Research Best Practices Conference
Date:9/14/2009

NCCN is holding the NCCN Oncology Research Best Practices Conference(TM), an interactive forum to discuss the regulatory and operational aspects of research and help identify areas in the clinical trial process where improvements can be made. Scheduled for October 26 - 27 in Bethesda, MD, the conference will include lectures, interactive workshops, and panel discussions on topics that challenge the conduct of oncology research as well as topics related to ethical considerations.

FORT WASHINGTON, Pa., Sept. 14 /PRNewswire-USNewswire/ -- Significant strides in the prevention, detection, and treatment of cancer have been made possible through clinical trials, however regulatory and ethical issues can pose challenges to clinical investigators. The National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers, is drawing on its collective expertise and holding the NCCN Oncology Research Best Practices Conference(TM) to review and discuss regulatory and operational aspects of research and help identify areas in the clinical trial process where improvements can be made.

The two-day conference being held October 26 - 27 in Bethesda, MD, will include lectures, interactive workshops, and panel discussions with audience participation on topics that challenge the conduct of oncology research as well as topics related to ethical considerations and maintaining and improving regulatory compliance. Attendees will learn about innovative practices and organizational structures that work and new ideas and perspectives that will lead to increased productivity and quality.

The conference is designed to be interactive and meet the needs of a multidisciplinary audience including oncology researchers, research nurses, Institutional Review Board (IRB) professionals, research administrators, academics, ethicists, government regulators, and industry sponsors on best practices in oncology research.

NCCN recognizes the importance of investing in clinical trials, which can result in changes in the standard of care and improved patient outcomes. Through the NCCN Oncology Research Program (ORP), more than $20 million of funding has been obtained to support investigator-initiated trials at NCCN Member Institutions to explore new avenues of clinical investigation and answer important scientific questions. The NCCN ORP recently launched a new platform, the Drug Development Research Grant Model that provides a mechanism for research on drugs in early stages of development.

Complete program details and online registration for the NCCN Oncology Research Best Practices Conference(TM) are available at NCCN.org.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.

The NCCN Member Institutions are: City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women's Cancer Center / Massachusetts General Hospital Cancer Center, Boston, MA; Duke Comprehensive Cancer Center, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.

For more information on NCCN, please visit NCCN.org.


'/>"/>
SOURCE National Comprehensive Cancer Network
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives
2. Fauquier Health System Holds a Food Show with a Twist Long Term Care Patients Hold the Judges Pen as Vendors Vie for Approval
3. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
4. Epilepsy Drug Holds Promise as Treatment for Alcoholism
5. Sunday, October 14, MSPP holds Sixth Annual Lucero Memorial Run and Latino Leadership Breakfast
6. Alzheimers Foundation of America Holds Fifth Annual National Memory Screening Day
7. European Patent Office Upholds Verathons IP Against Aircraft Medical Challenge
8. University Hospitals Case Medical Center finds new treatment holds promise for Tourette syndrome
9. Go Red For Women Holds Nationwide Casting Call to Find the Heart of Go Red
10. Fruit fly phlebotomy holds neuroscience promise
11. American Association for Dental Research holds 37th annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... offered by the American Association of Integrative Medicine and available for application on ... at the AutismOne 2017 Conference in Colorado Springs. , Ed Arranga, president of ...
(Date:3/28/2017)... ... March 28, 2017 , ... The ... in Atlantic City March 13-16, was a busy spot this year. Liz Solovay ... discussed strategies for preventing outbreaks among camp communities during the upcoming 2017 camping ...
(Date:3/28/2017)... Albertson, NY (PRWEB) , ... March 28, 2017 , ... Oily skin is a common ... with Advanced Dermatology has a lot to offer to the discussion of dealing ... good news is that there are many home remedies that can help remove the oily ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... “A Prophets Bones”: a thrilling adventure that ... Donald Quinn. , “There were things that his parents and teachers had asked of him ... way that he was going to defy the Almighty Creator. There were some who would ...
(Date:3/27/2017)... FL (PRWEB) , ... March 27, 2017 , ... ... new patients for clear braces. People who want straight teeth without the extensive ... Invisalign® in Clearwater, FL, without acquiring a referral. A custom-designed series of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... SAN FRANCISCO , March 28, 2017 ... market  is expected to reach a value of USD ... by Grand View Research, Inc. Proper closure of injured ... tissue,s structure and function. Postoperative leakages occur in 3% ... serious complication. They are responsible for one third of ...
(Date:3/27/2017)... -- Summary This report provides all ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/27/2017)... 2017  Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or ... shares of common stock in an underwritten public offering ... the Securities and Exchange Commission (the "SEC"). The offering ... can be no assurance as to whether or when ... actual size or terms of the offering. Cryoport also ...
Breaking Medicine Technology: